References
1. Mortality, G.B.D.; Causes of Death, C. Global, regional, and national
life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980-2015: A systematic analysis for the global
burden of disease study 2015. Lancet 2016 , 388 ,
1459-1544.
2. Dalal, A.A.; Christensen, L.; Liu, F.; Riedel, A.A. Direct costs of
chronic obstructive pulmonary disease among managed care patients.Int J Chron Obstruct Pulmon Dis 2010 , 5 , 341-349.
3. Vogelmeier, C.F.; Criner, G.J.; Martinez, F.J.; Anzueto, A.; Barnes,
P.J.; Bourbeau, J.; Celli, B.R.; Chen, R.; Decramer, M.; Fabbri,
L.M., et al. Global strategy for the diagnosis, management, and
prevention of chronic obstructive lung disease 2017 report: Gold
executive summary. Eur Respir J 2017 , 49 .
4. Hillas, G.; Perlikos, F.; Tsiligianni, I.; Tzanakis, N. Managing
comorbidities in copd. Int J Chron Obstruct Pulmon Dis2015 , 10 , 95-109.
5. Ozkaya, S.; Findik, S.; Atici, A.G. The costs of hospitalization in
patients with acute exacerbation of chronic obstructive pulmonary
disease. Clinicoecon Outcomes Res 2011 , 3 , 15-18.
6. Alshabanat, A.; Otterstatter, M.C.; Sin, D.D.; Road, J.; Rempel, C.;
Burns, J.; van Eeden, S.F.; FitzGerald, J.M. Impact of a copd
comprehensive case management program on hospital length of stay and
readmission rates. Int J Chron Obstruct Pulmon Dis 2017 ,12 , 961-971.
7. Inabnit, L.S.; Blanchette, C.; Ruban, C. Comorbidities and length of
stay in chronic obstructive pulmonary disease patients. COPD2018 , 15 , 355-360.
8. Wang, Y.; Stavem, K.; Dahl, F.A.; Humerfelt, S.; Haugen, T. Factors
associated with a prolonged length of stay after acute exacerbation of
chronic obstructive pulmonary disease (aecopd). Int J Chron
Obstruct Pulmon Dis 2014 , 9 , 99-105.
9. Agboado, G.; Peters, J.; Donkin, L. Factors influencing the length of
hospital stay among patients resident in blackpool admitted with copd: A
cross-sectional study. BMJ Open 2012 , 2 .
10. Limsuwat, C.; Mankongpaisarnrung, C.; Dumrongmongcolgul, N.; Nugent,
K. Factors influencing the length of hospital stay in patients with
acute exacerbations of chronic obstructive pulmonary disease admitted to
intensive care units. Qual Manag Health Care 2014 ,23 , 86-93.
11. Ford, E.S.; Murphy, L.B.; Khavjou, O.; Giles, W.H.; Holt, J.B.;
Croft, J.B. Total and state-specific medical and absenteeism costs of
copd among adults aged ≥ 18 years in the united states for 2010 and
projections through 2020. Chest 2015 , 147 , 31-45.
12. van Schayck, O.C.; Slok, A.H.; Kotz, D.; van Breukelen, G.;
Chavannes, N.H.; Rutten-van Mölken, M.P.; Kerstjens, H.A.; van der
Molen, T.; Asijee, G.M.; Dekhuijzen, P.N., et al.[effectiveness of the assessment of burden of copd tool: A
cluster-randomised controlled trial]. Ned Tijdschr Geneeskd2016 , 160 , D955.
13. Mulpuru, S.; McKay, J.; Ronksley, P.E.; Thavorn, K.; Kobewka, D.M.;
Forster, A.J. Factors contributing to high-cost hospital care for
patients with copd. Int J Chron Obstruct Pulmon Dis2017 , 12 , 989-995.
14. Wong, A.W.; Gan, W.Q.; Burns, J.; Sin, D.D.; van Eeden, S.F. Acute
exacerbation of chronic obstructive pulmonary disease: Influence of
social factors in determining length of hospital stay and readmission
rates. Can Respir J 2008 , 15 , 361-364.
15. Chen, Y.H.; Yao, W.Z.; Cai, B.Q.; Wang, H.; Deng, X.M.; Gao, H.L.;
Huang, J.S.; Wang, X.M. Economic analysis in admitted patients with
acute exacerbation of chronic obstructive pulmonary disease. Chin
Med J (Engl) 2008 , 121 , 587-591.
16. de la Iglesia, F.; Valiño, P.; Pita, S.; Ramos, V.; Pellicer, C.;
Nicolás, R.; Diz-Lois, F. Factors predicting a hospital stay of over 3
days in patients with acute exacerbation of chronic obstructive
pulmonary disease. J Intern Med 2002 , 251 ,
500-507.
17. Tsimogianni, A.M.; Papiris, S.A.; Stathopoulos, G.T.; Manali, E.D.;
Roussos, C.; Kotanidou, A. Predictors of outcome after exacerbation of
chronic obstructive pulmonary disease. J Gen Intern Med2009 , 24 , 1043-1048.
18. Quintana, J.M.; Unzurrunzaga, A.; Garcia-Gutierrez, S.; Gonzalez,
N.; Lafuente, I.; Bare, M.; de Larrea, N.F.; Rivas, F.; Esteban, C.
Predictors of hospital length of stay in patients with exacerbations of
copd: A cohort study. J Gen Intern Med 2015 , 30 ,
824-831.
19. Mushlin, A.I.; Black, E.R.; Connolly, C.A.; Buonaccorso, K.M.;
Eberly, S.W. The necessary length of hospital stay for chronic pulmonary
disease. JAMA 1991 , 266 , 80-83.
20. Crisafulli, E.; Ielpo, A.; Barbeta, E.; Ceccato, A.; Huerta, A.;
Gabarrus, A.; Soler, N.; Chetta, A.; Torres, A. Clinical variables
predicting the risk of a hospital stay for longer than 7 days in
patients with severe acute exacerbations of chronic obstructive
pulmonary disease: A prospective study. Respir Res 2018 ,19 , 261.
21. Neumeier, A.; Keith, R. Clinical guideline highlights for the
hospitalist: The gold and nice guidelines for the management of copd.J Hosp Med 2020 , 15 , e1-e2.
22. GOLD. Global strategy for the diagnosis, management, and prevention
of chronic obstructive pulmonary disease (revised 2018). Preprint
at https://goldcopdorg/ 2018 .
23. Chronic Obstructive Pulmonary Disease Committee. Respiratory
Society, C.M.A. [guideline for diagnosis and treatment of chronic
obstructive pulmonary disease (version 2013)]. Chin J Tuberc
Respir Dis 2013 , 4 , 255-264.
24. Dai, G.; Ran, Y.; Wang, J.; Chen, X.; Peng, J.; Li, X.; Deng, H.;
Xiao, M.; Zhu, T. Clinical differences between eosinophilic and
noneosinophilic acute exacerbation of chronic obstructive pulmonary
disease: A multicenter cross-sectional study. Mediators of
Inflammation 2020 , 2020 , 1059079.
25. Shujaat, A.; Minkin, R.; Eden, E. Pulmonary hypertension and chronic
cor pulmonale in copd. Int J Chron Obstruct Pulmon Dis2007 , 2 , 273-282.
26. Park, S.Y.; Lee, C.Y.; Kim, C.; Jang, S.H.; Park, Y.B.; Park, S.;
Hwang, Y.I.; Lee, M.G.; Jung, K.S.; Kim, D.G. One-year prognosis and the
role of brain natriuretic peptide levels in patients with chronic cor
pulmonale. J Korean Med Sci 2015 , 30 , 442-449.
27. Zhu, T.; Li, S.; Wang, J.; Liu, C.; Gao, L.; Zeng, Y.; Mao, R.; Cui,
B.; Ji, H.; Chen, Z. Induced sputum metabolomic profiles and oxidative
stress are associated with chronic obstructive pulmonary disease (copd)
severity: Potential use for predictive, preventive, and personalized
medicine. EPMA Journal 2020 .
28. Berry, C.E.; Wise, R.A. Mortality in copd: Causes, risk factors, and
prevention. COPD 2010 , 7 , 375-382.
29. Ko, F.W.S.; Chan, K.P.; Ngai, J.; Ng, S.S.; Yip, W.H.; Ip, A.; Chan,
T.O.; Hui, D.S.C. Blood eosinophil count as a predictor of hospital
length of stay in copd exacerbations. Respirology 2020 ,25 , 259-266.
30. Dai, M.Y.; Qiao, J.P.; Xu, Y.H.; Fei, G.H. Respiratory infectious
phenotypes in acute exacerbation of copd: An aid to length of stay and
copd assessment test. Int J Chron Obstruct Pulmon Dis2015 , 10 , 2257-2263.
31. Rinne, S.T.; Graves, M.C.; Bastian, L.A.; Lindenauer, P.K.; Wong,
E.S.; Hebert, P.L.; Liu, C.F. Association between length of stay and
readmission for copd. Am J Manag Care 2017 , 23 ,
e253-e258.
32. Ingadottir, A.R.; Beck, A.M.; Baldwin, C.; Weekes, C.E.;
Geirsdottir, O.G.; Ramel, A.; Gislason, T.; Gunnarsdottir, I.
Association of energy and protein intakes with length of stay,
readmission and mortality in hospitalised patients with chronic
obstructive pulmonary disease. Br J Nutr 2018 ,119 , 543-551.
33. Harries, T.H.; Thornton, H.V.; Crichton, S.; Schofield, P.; Gilkes,
A.; White, P.T. Length of stay of copd hospital admissions between 2006
and 2010: A retrospective longitudinal study. Int J Chron Obstruct
Pulmon Dis 2015 , 10 , 603-611.
34. Engel, B.; Schindler, C.; Leuppi, J.D.; Rutishauser, J. Predictors
of re-exacerbation after an index exacerbation of chronic obstructive
pulmonary disease in the reduce randomised clinical trial. Swiss
Med Wkly 2017 , 147 , w14439.
35. Li, L.S.; Caughey, G.; Johnston, K. Comorbidity associated with
referral to pulmonary rehabilitation in people hospitalized with chronic
obstructive pulmonary disease. J Cardiopulm Rehabil Prev2014 , 34 , 430-436.
36. Lin, S.H.; Perng, D.W.; Chen, C.P.; Chai, W.H.; Yeh, C.S.; Kor,
C.T.; Cheng, S.L.; Chen, J.J.; Lin, C.H. Increased risk of
community-acquired pneumonia in copd patients with comorbid
cardiovascular disease. Int J Chron Obstruct Pulmon Dis2016 , 11 , 3051-3058.
37. Akpınar, E.E.; Akpınar, S.; Ertek, S.; Sayın, E.; Gülhan, M.
Systemic inflammation and metabolic syndrome in stable copd patients.Tuberk Toraks 2012 , 60 , 230-237.
38. Barnes, P.J.; Celli, B.R. Systemic manifestations and comorbidities
of copd. Eur Respir J 2009 , 33 , 1165-1185.
39. Cilli, A.; Erdem, H.; Karakurt, Z.; Turkan, H.; Yazicioglu-Mocin,
O.; Adiguzel, N.; Gungor, G.; Bilge, U.; Tasci, C.; Yilmaz, G., et
al. Community-acquired pneumonia in patients with chronic obstructive
pulmonary disease requiring admission to the intensive care unit: Risk
factors for mortality. J Crit Care 2013 , 28 ,
975-979.
40. Mortensen, E.M.; Copeland, L.A.; Pugh, M.J.; Restrepo, M.I.; de
Molina, R.M.; Nakashima, B.; Anzueto, A. Impact of statins and ace
inhibitors on mortality after copd exacerbations. Respir Res2009 , 10 , 45.
41. Kubota, Y.; Asai, K.; Murai, K.; Tsukada, Y.T.; Hayashi, H.; Saito,
Y.; Azuma, A.; Gemma, A.; Shimizu, W. Copd advances in left ventricular
diastolic dysfunction. Int J Chron Obstruct Pulmon Dis2016 , 11 , 649-655.
42. Fossati, L.; Müller-Mottet, S.; Hasler, E.; Speich, R.; Bloch, K.E.;
Huber, L.C.; Ulrich Somaini, S. Long-term effect of vasodilator therapy
in pulmonary hypertension due to copd: A retrospective analysis.Lung 2014 , 192 , 987-995.
43. Weitzenblum, E. Chronic cor pulmonale. Heart 2003 ,89 , 225-230.
44. Wells, J.M.; Washko, G.R.; Han, M.K.; Abbas, N.; Nath, H.; Mamary,
A.J.; Regan, E.; Bailey, W.C.; Martinez, F.J.; Westfall, E., et
al. Pulmonary arterial enlargement and acute exacerbations of copd.N Engl J Med 2012 , 367 , 913-921.